|
HY-122331-100mg
|
MedChemexpress LLC
|
Norbormide [CAS 991-42-4]
|
|
|
|
|
HY-P80847-10uL
|
MedChemexpress LLC
|
Phospho-PKA RII Alpha (Ser99) Antibody
|
|
|
|
|
HY-P80847-100uL
|
MedChemexpress LLC
|
Phospho-PKA RII Alpha (Ser99) Antibody
|
|
|
|
|
HY-P80847-50uL
|
MedChemexpress LLC
|
Phospho-PKA RII Alpha (Ser99) Antibody
|
|
|
|
|
HY-13402A-10mg
|
MedChemexpress LLC
|
Varespladib (sodium) [CAS 172733-42-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402A-100mg
|
MedChemexpress LLC
|
Varespladib (sodium) [CAS 172733-42-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402A-25mg
|
MedChemexpress LLC
|
Varespladib (sodium) [CAS 172733-42-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402A-5mg
|
MedChemexpress LLC
|
Varespladib (sodium) [CAS 172733-42-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402A-50mg
|
MedChemexpress LLC
|
Varespladib (sodium) [CAS 172733-42-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402-10mg
|
MedChemexpress LLC
|
Varespladib [CAS 172732-68-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402-100mg
|
MedChemexpress LLC
|
Varespladib [CAS 172732-68-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402-25mg
|
MedChemexpress LLC
|
Varespladib [CAS 172732-68-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402-5mg
|
MedChemexpress LLC
|
Varespladib [CAS 172732-68-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402-50mg
|
MedChemexpress LLC
|
Varespladib [CAS 172732-68-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-103197-10mg
|
MedChemexpress LLC
|
2-Methoxyidazoxan (monohydrochloride) [CAS 109544-45-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103197-100mg
|
MedChemexpress LLC
|
2-Methoxyidazoxan (monohydrochloride) [CAS 109544-45-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103197-5mg
|
MedChemexpress LLC
|
2-Methoxyidazoxan (monohydrochloride) [CAS 109544-45-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103197-50mg
|
MedChemexpress LLC
|
2-Methoxyidazoxan (monohydrochloride) [CAS 109544-45-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1016B-10mg
|
MedChemexpress LLC
|
BQ-3020 (ammonium)
|
|
|
|
|
HY-P1016B-5mg
|
MedChemexpress LLC
|
BQ-3020 (ammonium)
|
|
|
|
|
HY-108591-1mg
|
MedChemexpress LLC
|
L-364,373 [CAS 103342-82-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108591-10mg
|
MedChemexpress LLC
|
L-364,373 [CAS 103342-82-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108591-25mg
|
MedChemexpress LLC
|
L-364,373 [CAS 103342-82-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108591-5mg
|
MedChemexpress LLC
|
L-364,373 [CAS 103342-82-1]
|
|
Neuroscience-Neuromodulation
|
|
